Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Acute myeloid leukemia with Charcot-Leyden crystals.

Manny JS, Ellis LR.

Blood. 2012 Jul 19;120(3):503. No abstract available.

2.

Charcot-Leyden crystals and bone marrow necrosis in acute myeloid leukemia.

Radujkovic A, Bellos F, Andrulis M, Ho AD, Hundemer M.

Eur J Haematol. 2011 May;86(5):451-2. doi: 10.1111/j.1600-0609.2011.01594.x. Epub 2011 Mar 30. No abstract available.

PMID:
21342270
3.

Charcot-Leyden crystals associated with acute myeloid leukemia: case report and literature review.

Khrizman P, Altman JK, Mohtashamian A, Peterson L, Chen YH, Tallman MS.

Leuk Res. 2010 Dec;34(12):e336-8. doi: 10.1016/j.leukres.2010.08.014. Epub 2010 Oct 16. Review. No abstract available.

PMID:
20956014
4.

Acute myeloid leukaemia with mutated NPM1 presenting with extensive bone marrow necrosis and Charcot-Leyden crystals.

Taylor G, Ivey A, Milner B, Grimwade D, Culligan D.

Int J Hematol. 2013 Sep;98(3):267-8. doi: 10.1007/s12185-013-1394-9. Epub 2013 Jul 25.

PMID:
23884732
5.

Significance of Charcot Leyden crystals in liver cytology-A case report.

Thakral D, Agarwal P, Saran RK, Saluja S.

Diagn Cytopathol. 2015 May;43(5):392-4. doi: 10.1002/dc.23228. Epub 2014 Oct 28.

PMID:
25350873
6.

Charcot-Leyden crystals in acute myeloid leukemia.

van de Kerkhof D, Scharnhorst V, Huysentruyt CJ, Brands-Nijenhuis AV, Ermens AA.

Int J Lab Hematol. 2015 Aug;37(4):e100-2. doi: 10.1111/ijlh.12336. Epub 2015 Mar 9. No abstract available.

PMID:
25754678
7.

Acute myeloid leukemia with bone marrow necrosis and Charcot Leyden crystals.

Vermeersch P, Zachee P, Brusselmans C.

Am J Hematol. 2007 Nov;82(11):1029. No abstract available.

8.

Demonstration of Charcot-Leyden crystals in eosinophilic cystitis.

Staribratova D, Belovejdov V, Staikov D, Dikov D.

Arch Pathol Lab Med. 2010 Oct;134(10):1420. doi: 10.1043/2009-0604-LE.1. No abstract available.

PMID:
20923292
9.

Charcot-Leyden crystals in the trephine biopsy of a patient with a FIP1L1-PDGFRA - positive myeloproliferative disorder.

Lyall H, O'Connor S, Clark D.

Br J Haematol. 2007 Aug;138(4):405. Epub 2007 Jun 25. No abstract available.

PMID:
17593250
10.

Autofluorescent Charcot-Leyden crystals.

Lo JW, Fung CH.

Arch Pathol Lab Med. 1992 Nov;116(11):1101. No abstract available.

PMID:
1444732
11.

Charcot-Leyden crystals in human bone marrow.

Smith H, Forbes IM.

Pathology. 1972 Oct;4(4):279-94. No abstract available.

PMID:
4509035
12.

Charcot--Leyden crystals in fine needle aspiration (FNA) cytology of acute myeloid leukaemia.

Rubin A, Crawford S.

Cytopathology. 1997 Jun;8(3):211-3. No abstract available.

PMID:
9202899
13.

Charcot-Leyden crystals.

Grigoriadis G, Anderson MA, Whitehead S.

Intern Med J. 2010 Nov;40(11):792. doi: 10.1111/j.1445-5994.2010.02353.x. No abstract available.

PMID:
21155159
14.

Identification of Charcot-Leyden crystals by electron microscopy.

Carson HJ, Buschmann RJ, Weisz-Carrington P, Choi YS.

Ultrastruct Pathol. 1992 Jul-Aug;16(4):403-11.

PMID:
1502737
15.
16.

Charcot Leyden crystals in acute myeloid leukemia.

Ahluwalia J, Das R, Malhotra P, Verma S, Garewal G.

Am J Hematol. 2003 Jun;73(2):141. No abstract available.

17.

Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals.

Weller PF, Goetzl EJ, Austen KF.

Proc Natl Acad Sci U S A. 1980 Dec;77(12):7440-3.

18.

Localization of Charcot-Leyden crystal protein in individual morphological phenotypes of human basophils stimulated by f-Met peptide.

Dvorak AM, MacGlashan DW, Warner JA, Letourneau L, Morgan ES, Lichtenstein LM, Ackerman SJ.

Clin Exp Allergy. 1997 Apr;27(4):452-74. Review.

PMID:
9146940
19.

Discrepant bone-marrow aspirations in leukaemia.

Jacobs P.

Lancet. 1977 Aug 13;2(8033):355-6. No abstract available.

PMID:
69962
20.

Aggressive systemic mastocytosis with Charcot-Leyden crystals-associated crystal storing histiocytosis in bone marrow.

Alayed KM, Alabdulaali MK, Alkhairy KS, Elnour S, Alhajjaj A.

Pathology. 2010 Jan;42(1):85-7. doi: 10.3109/00313020903434652. No abstract available.

PMID:
20025488

Supplemental Content

Support Center